I’m fundraising for the Ottawa Hospital Cancer Centre Emergency Patient Fund. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving https://t.co/pMZX3q4Wpf
Love how @SIOGorg involves patient partners in the meeting. Learning so much from Beverly Canin on how to engage patients in shared decision making. See them as a person #siog2025
Great talk by @SaurNicole about the role of health care providers in shared decision making - and how sacred that role is. Older adults are highly sensitive to how HCPs frame risks and benefits. Ageism and biases are thus important to recognize and address #siog2025#gerionc
Great talk on factors affecting family involvement in decision making by Dr Dijkman
Many factors - depends on cultural norms of decision making (individual vs family); frailty of patient; family structure: family member itself
#gerionc#siog2025
Great talk by my Canadian 🇨🇦colleague @UBC@kristenhaase about the systemic presence of ageism and how it affects shared decision making. Ageism is common in the healthcare system - but can occur in patients themselves! (I’m too old for treatment). #siog2025
Last batch! 3/3. Also kudos to speakers at #siog2025 including @UHN Susie Monginot for presenting about the work they do in the Older Adults cancer clinic in Toronto
Amazing work by my Canadian 🇨🇦 colleagues in #gerionc Research ranges from from outcomes in surgery and radiation, GA prior to CAR-T, equity, and exercise. #siog2025 1/3
Amazing work by my Canadian 🇨🇦 colleagues in #gerionc Research ranges from from outcomes in surgery and radiation, GA prior to CAR-T, equity, and exercise. #siog2025 1/3
Amazing work by my Canadian 🇨🇦 colleagues in #gerionc Research ranges from from outcomes in surgery and radiation, GA prior to CAR-T, equity, and exercise. #siog2025 1/3
So proud of @OttawaHospital Dr. Terry Ng and team in running a large multi centre study about whether the frequency of bone modifying agents can be decreased to q26wk in pt with met ca to the bones #ESMO25 - the answer: there is no difference in patient symptoms/fan and SREs
Amazing accomplishment - well deserved and couldn’t happen to a nicer person! She’s definitely had a positive impact on the careers of many oncologists - women and men! #ESMO25
🚨New @ASCO Guideline Alert! 🌍
Honored to have worked alongside @EnriqueSoto8 & cols in developing this guideline
Check out the latest recommendations on GA, designed to improve care worldwide
📄Full guideline: https://t.co/8pgmQiAqEs
🎙️Don’t miss the accompanying podcast!
It’s been an amazing #cgoc25. Great turnout for our pre-conference #geriatric assessment workshop. Great talks and wonderful conversations and bidirectional learning!
We are hosting the next Canadian Geriatric Oncology Conference in beautiful Vancouver!!! We have an exciting agenda for the day ranging from how to implement and sustain geriatric oncology at your centre to our ever popular geriatric assessment workshop! #gerionc
Congratulations to the recipients of ICR’s 2025 Early Career Researcher Award!
Their research will help improve cancer treatments and advance health decision-making, care and equity to better support cancer patients.
Learn more: https://t.co/PWLQtAiT4l
We are hosting the next Canadian Geriatric Oncology Conference in beautiful Vancouver!!! We have an exciting agenda for the day ranging from how to implement and sustain geriatric oncology at your centre to our ever popular geriatric assessment workshop! #gerionc
We are hosting the next Canadian Geriatric Oncology Conference in beautiful Vancouver!!! We have an exciting agenda for the day ranging from how to implement and sustain geriatric oncology at your centre to our ever popular geriatric assessment workshop! #gerionc
Nearly 60% of new cancer cases in Canada occur in older adults.
The 2025 Canadian Geriatric Oncology Conference is your chance to get practical, evidence-based strategies for their care.
🧠 Expert-led. Patient-focused.
Save your seat: https://t.co/jChpGxGyt5
#CGOC25#MedOnc
#ASCO25#plenary
If the graph on the left is practice changing, the graph on the right is urgently practice changing.
Cost to health systems-$15K to $18K a month vs $100-$150 a month.
ATOMIC trial vs CHALLENGE trial.
#ASCO25@ASCO@NEJM
✅ Exercise Saves Lives After Colon Cancer
➡️ come watch Dr Chris Booth present the results of the ph3 CO.21 CHALLENGE study - don’t walk, run! 🏃🏃🏻♂️🏃
Hall B1 430-6pm
🙏 to our patients, my GI group @CDNCancerTrials 🇨🇦 and our partner @GICancer 🇦🇺🇳🇿for sticking with this trial over the past 15 years!
#trialsthatmatter
ATTN @CAMO_ACOM MO members & trainees 🇨🇦
👇invite you to check out our Biennial Report report 📝…and see what CAMO has been doing to advance our mission of empowering you to advance cancer care 🌼
👋 if you’re a 🇨🇦 MO & not a member - pls DM me, happy to send u a copy & invite you to become a member!